Lihui Bai

ID: 1b83bea9-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves Sandoz’s ENVEEZU™ (aflibercept-abzv)

Big Molecule Watch · August 14, 2024

Outlook Therapeutics Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma)

Big Molecule Watch · July 12, 2024

FDA Approves Amgen’s BKEMV, the First Eculizumab Biosimilar

Big Molecule Watch · June 7, 2024

PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid

Big Molecule Watch · May 1, 2024

FDA Approves First Gene Therapy to Treat Children with Metachromatic Leukodystrophy

Big Molecule Watch · March 28, 2024